Speciality Medicines Limited (BOM:544738)

Market Cap	1.84B
Revenue (ttm)	761.14M +88.2%
Net Income	130.33M +781.0%
EPS	20.11 +313.1%
Shares Out	8.79M
PE Ratio	10.39
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,000
Open	196.15
Previous Close	202.00
Day's Range	196.15 - 207.00
52-Week Range	121.10 - 381.20
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 28, 2026

About Speciality Medicines

Speciality Medicines Limited engages in the manufacturing, marketing and distribution of finished formulations of specialty pharmaceutical products in India and internationally. The company offers tablets, capsules, cream, syrups, eye drops, gel, infusion, inhalation, inhaler, injection, nasal spray, ointment, ophthalmic, oral solution, oral suspension, sachet, and suspension for oncology, immunology, neurology, and rare diseases therapeutic areas. It also provides patient, hospitals, institutions and NGO supplies, validated controlled supply m...

• Industry: Pharmaceutical Preparations
• Founded: 2021
• Country: India
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544738

Financial Performance

In fiscal year 2026, Speciality Medicines's revenue was 761.14 million, an increase of 30.62% compared to the previous year's 582.71 million. Earnings were 130.33 million, an increase of 81.11%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 17, 2026

Data Sources Report a data error